ASO Author Reflections: Preoperative Malignant Risk Assessment for Small (≤ 20 mm) Nonfunctioning Pancreatic Neuroendocrine Tumors

Andreasi V, Ricci C, Partelli S, et al. Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis. J Endocrinol Invest. 2022;45(4):705–18.

Article  CAS  PubMed  Google Scholar 

Nanno Y, Toyama H, Matusmoto I, et al. Reappraisal of malignant risk assessment for small (≤20 mm) non-functioning pancreatic neuroendocrine tumors. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13193-0.

Article  PubMed  Google Scholar 

Mizumoto T, Toyama H, Terai S, et al. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics. Pancreatology 2017;17(6):956–61.

Article  PubMed  Google Scholar 

Nanno Y, Matsumoto I, Zen Y, et al. Pancreatic duct involvement in well-differentiated neuroendocrine tumors is an independent poor prognostic factor. Ann Surg Oncol. 2017;24:1127–33.

Article  PubMed  Google Scholar 

Ricci C, Casadei R, Taffurelli G, et al. Sporadic small (≤20 mm) nonfunctioning pancreatic neuroendocrine neoplasm: is the risk of malignancy negligible when adopting a more conservative strategy? A systematic review and meta-analysis. Ann Surg Oncol. 2017;24(9):2603–10.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif